Aldrin Yim is a PhD candidate and Markey Scholar in the Computation and System Biology program at Washington University, School of Medicine. His research focuses on applying big data analytics and machine learning approaches in studying neurological diseases and cancer. He is also the founding CEO of Codex Genetics Limited, which provides precision medicine solutions to patients and hospitals in Asia.
